ResearchAndMarkets.com added two related global market studies to its offering in Dublin on Sept. 22 and 23, 2026: the Viral Vector Manufacturing Market - Global Forecast to 2036 and the Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036). The viral vector manufacturing market was valued at USD 3.52 billion in 2025, estimated at USD 4.18 billion in 2026 and projected to reach USD 12.84 billion by 2036 at a CAGR of 11.8%. The broader gene transfer technologies report projects robust growth through 2036 as gene and cell therapies, genomic medicine, genome editing and advanced delivery platforms expand. Viral vectors are engineered carriers that deliver genetic material into target cells and support gene therapy, engineered cell therapy, vaccines, regenerative medicine and research. The studies identify growing clinical pipelines, regulatory approvals, precision-medicine investment, biotechnology research, manufacturing outsourcing and technology advances as growth drivers, while high costs, complex production, stringent regulation, limited skilled personnel, scalability constraints, supply-chain and quality-control challenges, long-term safety concerns and pricing and intellectual-property pressures remain barriers. North America currently leads or holds a significant share, Europe remains important, and Asia-Pacific is expected to grow fastest or strongly. The reports assess viral and non-viral delivery, genome editing, ex vivo and in vivo approaches, manufacturing scale, applications, end users, regional markets and competitive developments.